Could your walk reveal dementia? new study investigates
NCT ID NCT07448909
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aims to understand how walking patterns, body composition, and a blood protein called BDNF differ between older adults with mild cognitive impairment and healthy older adults. Researchers will measure gait, handgrip strength, and cognitive function in 60 participants aged 50 and older. The goal is to find early signs of dementia through simple physical and blood tests, not to provide treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 60 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Feb 2026
An estimate. Start dates often move.
- Expected to finish
-
Dec 2029
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
USM memory clinic
- Ages
-
50 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Older adults aged 50 years and above * Able to ambulate independently without the use of walking aids * Must be able to understand instructions, communicate effectively * Free from any acute or unstable medical conditions at the time of assessment. Healthy older adults group: -No history or symptoms of cognitive impairments and have normal cognitive screening results. Mild Cognitive Impairment (MCI) group: -Must fulfill established diagnostic criteria for MCI, showing measurable cognitive decline without significant functional impairment and without a diagnosis of dementia. Exclusion Criteria: * Present with any diagnosed neurological disorder such as stroke or Parkinson's disease * History of psychiatric illness, including major depressive disorder. * Individuals with uncontrolled cardiovascular, metabolic, or endocrine conditions * Have significant visual, auditory, or musculoskeletal impairments that may influence gait performance * Currently taking medications known to affect cognitive or motor function * Unable to provide written informed consent
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Mild cognitive impairment (MCI) are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
School of Health Sciences
Kota Bharu, Kelantan, 16150, Malaysia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Zapping the brain to sharpen mind and stride
- Zapping the brain at 10 hz may help older adults stay steady
- Robot arm meets virtual reality to train the Parkinson's brain
- Three brain tests combined in one study to spot dementia earlier
- A brain zapping and tai chi combo may slow memory decline
- Can a dead probiotic revive aging brains?